Hinge Health, Inc. HNGE
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 168.31M | 109.07M | -510.27M | -528.26M | -533.24M |
| Total Depreciation and Amortization | 2.88M | 2.02M | 2.10M | 2.13M | 2.18M |
| Total Amortization of Deferred Charges | 74.04M | 64.79M | 56.58M | 49.67M | 44.57M |
| Total Other Non-Cash Items | 71.46M | 88.99M | 660.86M | 649.92M | 634.25M |
| Change in Net Operating Assets | 6.31M | 25.93M | 329.00K | -2.01M | -1.87M |
| Cash from Operations | 322.99M | 290.79M | 209.60M | 171.44M | 145.89M |
| Capital Expenditure | -10.03M | -666.00K | -740.00K | -708.00K | -457.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -97.35M | 0.00 | 0.00 | -4.00M | -4.00M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 82.21M | -19.09M | -43.61M | -109.06M | -74.72M |
| Cash from Investing | -25.17M | -19.75M | -44.35M | -113.76M | -79.18M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 16.90M | 17.23M | 265.52M | 265.20M | 256.67M |
| Repurchase of Common Stock | -361.74M | -239.28M | -473.52M | -360.26M | -272.26M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -288.00K | -288.00K | -59.42M | -55.42M | -57.67M |
| Cash from Financing | -345.13M | -222.34M | -267.42M | -150.47M | -73.26M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -47.31M | 48.69M | -102.17M | -92.79M | -6.55M |